Body composition and plasma levels of inflammatory biomarkers in COPD

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 1027-1033

  Eagan, T M L ^a,e   Aukrust, P ^c   Ueland, T ^c   Hardie, J A ^a   Johannessene, A ^a   Mollnes, T E ^c   Dama, J K ^c,d   Bakke, P S ^a,b   Wagner, P D ^e  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Cachexia; Chronic obstructive pulmonary disease; Inflammation

Indexed keywords

C REACTIVE PROTEIN; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; ENZYME IMMUNOASSAY; FAT FREE MASS; FAT MASS; FEMALE; HUMAN; HYPOXEMIA; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; SMOKING HABIT; STEROID THERAPY;

ADULT; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; CACHEXIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPROTEGERIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 78349281205     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00194209     Document Type: Article

References (38)

1. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532. (Pubitemid 44794666)
2. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet 2003; 362: 1053-1061.
3. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997; 127: 1072-1079.
4. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008; 31: 492-501.
5. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59. (Pubitemid 41716377)
6. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001; 164: 1712-1717. (Pubitemid 33124163)
7. Di Francia M, Barbier D, Mege JL, et al. Tumor necrosis factoralpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455. (Pubitemid 24356667)
8. Takabatake N, Nakamura H, Abe S, et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1215-1219. (Pubitemid 29202558)
9. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1414-1418. (Pubitemid 33124019)
10. Itoh T, Nagaya N, Yoshikawa M, et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 879-882. (Pubitemid 39346483)
11. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
12. Broekhuizen R, Grimble RF, Howell WM, et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism. Am J Clin Nutr 2005; 82: 1059-1064. (Pubitemid 43779765)
13. Van Helvoort HA, Heijdra YF, Thijs HM, et al. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 2006; 38: 1543-1552. (Pubitemid 44373772)
14. Shin KC, Chung JH, Lee KH. Effects of TNF-alpha and leptin on weight loss in patients with stable chronic obstructive pulmonary disease. Korean J Intern Med 2007; 22: 249-255.
15. Kurosaki H, Ishii T, Motohashi N, et al. Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD. Intern Med 2009; 48: 41-48.
16. Eagan TM, Ueland T, Wagner PD, et al. Systemic inflammatory markers in chronic obstructive pulmonary disease: results from the Bergen COPD Cohort Study. Eur Respir J 2010; 35: 540-548.
17. Broekhuizen R, Vernooy JH, Schols AM, et al. Leptin as local inflammatory marker in COPD. Respir Med 2005; 99: 70-74. (Pubitemid 40017387)
18. Horowitz MC, Xi Y, Wilson K, et al. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001; 12: 9-18. (Pubitemid 32294582)
19. Nabipour I, Kalantarhormozi M, Larijani B, et al. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. Metabolism 2010; 59: 742-747.
20. Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173: 1316-1325. (Pubitemid 43900705)
21. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. (Pubitemid 17055592)
22. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
23. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28: 964-974. (Pubitemid 29525041)
24. Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 2002; 26: 953-960. (Pubitemid 34756178)
25. Balasubramanian VP, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Curr Opin Pulm Med 2006; 12: 106-112. (Pubitemid 44384784)
26. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
27. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002; 121: Suppl. 5, 127S-130S.
28. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 1286-1293.
29. Cohen RI, Marzouk K, Berkoski P, et al. Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema. Chest 2003; 124: 1365-1372. (Pubitemid 37304036)
30. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
31. Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61: 23-28. (Pubitemid 43106973)
32. Dempsey PW, Doyle SE, He JQ, et al. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14: 193-209. (Pubitemid 36693141)
33. Graat-Verboom L, Spruit MA, van den Borne BE, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respir Med 2009; 103: 1143-1151.
34. Nguyen XM, Lane J, Smith BR, et al. Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J Gastrointest Surg 2009; 13: 1205-1212.
35. Hofso D, Ueland T, Hager H, et al. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol 2009; 161: 451-458.
36. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
37. Skolnik EY, Marcusohn J. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev 1996; 7: 161-173. (Pubitemid 27198075)
38. Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis 2008; 5: 35-41. (Pubitemid 351903614)